DexCom Stock Jumps 5% After Elliott Management Takes Activist Stake and Two Board Seats

# DexCom Stock Jumps 5% After Elliott Management Takes Activist Stake and Two Board Seats

> **Quick answer:** DexCom (DXCM) shares surged more than 5% after hours on May 15, 2026 after activist investor Elliott Management disclosed a substantial stake in the company and struck a deal for two independent board seats. Elliott called the $15.3 billion CGM market "meaningfully underpenetrated" and sees a clear path to significant margin expansion — a bet that DexCom's best years are still ahead despite a rocky 2025.

DexCom stock Elliott Management activist stake news broke just 13 minutes before the company's 2026 investor day began on May 14, sending DXCM shares up more than 6% to $61.69 the following session. The move is a vote of confidence from one of Wall Street's most feared activist funds — but it also signals that Elliott sees execution problems the market has been pricing in for months. Here is what investors need to know.

## What Happened: Elliott Takes Activist Stake in DexCom Ahead of Investor Day

Elliott Management, the $70 billion activist hedge fund run by Paul Singer, disclosed a substantial stake in DexCom (DXCM) on May 14, 2026, timing the announcement to land just before DexCom's 2026 investor day webcast at 4:15 PM ET.

The deal gives Elliott two board seats in exchange for its cooperation with the company. DexCom agreed to appoint two new independent directors, specifically targeting candidates with medtech leadership or lean operations experience. As part of the same agreement, DexCom reconstituted its technology committee as the new **operations and innovation committee**, expanding its oversight to include quality assurance alongside the technical roadmap.